Acute Medication Use in Patients With Migraine Treated With Monoclonal Antibodies Acting on the CGRP Pathway: Results From a Multicenter Study and Proposal of a New Index

INTRODUCTION: Assessing the impact of migraine preventive treatments on acute medication consumption is important in clinical evaluation. The number of acute medication intakes per each monthly migraine day (MMD) could provide insights on migraine burden and represent a new proxy of treatment effect...

Descripción completa

Detalles Bibliográficos
Autores principales: Sette, Lucia, Caponnetto, Valeria, Ornello, Raffaele, Nežádal, Tomáš, Čtrnáctá, Dana, Šípková, Jitka, Matoušová, Zuzana, Sacco, Simona
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Neurology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8918478/
https://www.ncbi.nlm.nih.gov/pubmed/35295829
http://dx.doi.org/10.3389/fneur.2022.846717

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8918478/
https://www.ncbi.nlm.nih.gov/pubmed/35295829
http://dx.doi.org/10.3389/fneur.2022.846717

Ejemplares similares